Advertisement

Sickle Cell Disease

  • Eustathios Kenanidis
  • Panagiotis Kakoulidis
  • Panagiotis Lepetsos
  • Michael Potoupnis
  • Eleftherios Tsiridis
  • Emre Toğrul
  • Bülent Atilla
  • Duy L. Phan
  • Ran Schwarzkopf
Chapter

Abstract

Please check the hierarchy of the section headings and confirm if correct.

References

  1. 1.
    Hammer M, Geier KA, Aksoy S. Perioperative care for patients with sickle cell who are undergoing total hip replacement as treatment for osteonecrosis. Orthop Nurs. 2003;22(6):384–97.CrossRefPubMedGoogle Scholar
  2. 2.
    Kamath AF, Mcgraw MH, Israelite CL, Kamath AF, Mcgraw MH, Israelite CL. Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease. World J Orthop. 2015;6(10):776–82.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Jeong GK, Ruchelsman DE. Total hip arthroplasty in sickle cell hemoglobinopathies. J Am Acad Orthop Surg. 2005;13:208–17.CrossRefPubMedGoogle Scholar
  4. 4.
    Ilyas I, Moreau P. Simultaneous bilateral total hip arthroplasty in sickle celldisease. J Arthroplast. 2002;17:441–5.CrossRefGoogle Scholar
  5. 5.
    Poignard A, Bouhou M, Homma Y, Hernigou P. Septic arthritis of the hip in adults with sickle cell anemia. Orthop Rev. 2011;3:e1.CrossRefGoogle Scholar
  6. 6.
    Moran MC, Huo MH, Garvin KL, Pel-licci PM, Salvati EA. Total hip arthroplasty in sickle cell hemoglobinopathy. Clin Orthop. 1993;294:140–8.Google Scholar
  7. 7.
    Gunderson C, D’Ambrosia RD, Shoji H. Total hip replacement in patients with sickle-cell disease. J Bone Joint Surg Am. 1977;59:760–2.CrossRefPubMedGoogle Scholar
  8. 8.
    Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM. The perioperative complication rate oforthopedic surgery in sickle cell disease: report of the National sickle cell surgery study group. Am J Hematol. 1999;62:129–38.CrossRefPubMedGoogle Scholar
  9. 9.
    Clarke HJ, Jinnah RH, Brooker AF, Michaelson JD. Total replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg Br. 1989;71:465–70.CrossRefPubMedGoogle Scholar
  10. 10.
    Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br. 1992;74:367–71.CrossRefPubMedGoogle Scholar
  11. 11.
    Bishop AR, Roberson JR, Eckman JR, Fleming LL. Total hip arthroplasty inpatients who have sickle-cell hemoglo-binopathy. J Bone Joint Surg Am. 1988;70:853–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Epps C, Castro O. Complications of total hip replacement in sickle cell disease. Orthop Transactions. 1978;2:236–7.Google Scholar
  13. 13.
    Hanker GJ, Amstutz HC. Osteonecrosis of the hip in the sickle cell diseases: treatment and complications. J Bone Joint Surg Am. 1988;70:499–506.CrossRefPubMedGoogle Scholar
  14. 14.
    Hickman JM, Lachiewicz PF. Results and complications of total hip arthroplastiesin patients with sickle-cell hemoglobin-opathies: role of cementless components. J Arthroplast. 1997;12:420–5.CrossRefGoogle Scholar
  15. 15.
    Al-Mousawi F, Malki A, Al-Aradi A, Al-Bagali M, Al-Sadadi A, Booz MM. Total hip replacement in sickle cell disease. Int Orthop. 2002;26:157–61.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Gulati Y, Sharma M, Bharti B, Bahl V, Bohra I. Short term results of cementless total hip arthroplasty in sicklers. Indian J Orthop. 2015;49(4):447–51.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Issa K, Naziri Q, Maheshwari AV, Rasquinha VJ, Delanois RE, Mont MA. Excellent results and minimal complications of total hip arthroplasty in sickle cell hemoglobinopathy at mid-term follow-up using cementless prosthetic components. J Arthroplast. 2013;28:1693–8.CrossRefGoogle Scholar
  18. 18.
    Hernigou P, Zilber S, Filippini P, Mathieu G, Poignard A, Galacteros F. Total THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res. 2008;466:300–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Perfetti DC, Boylan MR, Naziri Q, Khanuja HS, Urban WP. Does sickle cell disease increase risk of adverse outcomes following total hip and knee Arthroplasty? A Nationwide database study. J Arthroplast. 2015;30:547–51.CrossRefGoogle Scholar
  20. 20.
    Hug KT, Gupta AK, Wellman SS, Bolognesi MP, Attarian DE. Creation of a femoral cortical window to facilitate total hip arthroplasty in patients with sickle cell hemoglobinopathies. J Arthroplasty. 2013;28(2):323–5. doi: 10.1016/j.arth.2012.06.021. Epub 2012 Aug 3. PMID: 22,868,077CrossRefPubMedGoogle Scholar
  21. 21.
    Patel YD, Szczech BW, Patel S, Issa K, Kapadia BH, Mont MA. Management strategies for total hip arthroplasty in sickle cell patients. J Long Term Eff Med Implants. 2014;24(2–3):219–24.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Eustathios Kenanidis
    • 1
  • Panagiotis Kakoulidis
    • 1
  • Panagiotis Lepetsos
    • 2
  • Michael Potoupnis
    • 3
  • Eleftherios Tsiridis
    • 3
  • Emre Toğrul
    • 4
  • Bülent Atilla
    • 5
  • Duy L. Phan
    • 6
  • Ran Schwarzkopf
    • 7
  1. 1.Academic Orthopaedic UnitAristotle University Medical SchoolThessalonikiGreece
  2. 2.Fourth Orthopaedic DepartmentKAT HospitalAthensGreece
  3. 3.Academic Orthopaedic UnitPapageorgiou General Hospital, Aristotle University Medical SchoolThessalonikiGreece
  4. 4.Ortopedia HospitalAdanaTurkey
  5. 5.Faculty of MedicineHacettepe UniversityAnkaraTurkey
  6. 6.Kaiser PermanenteOaklandUSA
  7. 7.Department of Orthopaedic SurgeryNYU Langone Health Orthopaedic Hospital, Hospital for Joint DiseasesNew YorkUSA

Personalised recommendations